Literature DB >> 26519754

Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma.

Maria E Kavanagh1, Melissa J Conroy1, Niamh E Clarke1, Niamh T Gilmartin1, Katie E O'Sullivan1, Ronan Feighery1, Finbar MacCarthy2, Dermot O'Toole2, Narayanasamy Ravi1, John V Reynolds1, Jacintha O'Sullivan1, Joanne Lysaght3.   

Abstract

The incidence of oesophageal adenocarcinoma (OAC), arising from reflux-induced Barrett oesophagus (BO), is increasing dramatically. T-cells have recently been implicated in the initiation of oesophagitis; however, their role in the progression from oesophagitis to BO and OAC has not been fully elucidated. Previous studies have examined the secreted cytokines from oesophageal tissue during disease progression but this study is the first to examine the activation phenotype and the inflammatory profile of CD4(+) and CD8(+) T-cells in human oesophagitis, BO and OAC tissue. Results demonstrated significantly higher levels of IL-4 producing CD4(+) T-cells and secreted levels of IL-6, confirming a Th2 phenotype in BO. In OAC tissue, both pro- and anti-inflammatory cytokines were secreted, with significantly higher levels of IL-6, IL-1β, TNF-α, IFN-γ, IL-2 and IL-10 compared with normal oesophageal tissue. In addition, CD4(+) T-cells infiltrating OAC tissue displayed a decreased activation profile, with significantly lower CD45RO and CD69 expression compared with normal tissue. Data from this study suggest that factors in the tissue microenvironment may alter T-cell phenotype and function early during oesophageal disease progression and may represent targets for immune intervention.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Barrett oesophagus; Inflammation; Oesophageal adenocarcinoma; Oesophagitis; T-cells

Mesh:

Substances:

Year:  2015        PMID: 26519754     DOI: 10.1016/j.canlet.2015.10.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Authors:  Smruthy Sivakumar; F Anthony San Lucas; Tina L McDowell; Wenhua Lang; Li Xu; Junya Fujimoto; Jianjun Zhang; P Andrew Futreal; Junya Fukuoka; Yasushi Yatabe; Steven M Dubinett; Avrum E Spira; Jerry Fowler; Ernest T Hawk; Ignacio I Wistuba; Paul Scheet; Humam Kadara
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

2.  Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.

Authors:  Vinicius J Campos; Guilherme S Mazzini; José F Juchem; Richard R Gurski
Journal:  J Gastrointest Surg       Date:  2019-11-19       Impact factor: 3.452

Review 3.  Evolution and progression of Barrett's oesophagus to oesophageal cancer.

Authors:  Sarah Killcoyne; Rebecca C Fitzgerald
Journal:  Nat Rev Cancer       Date:  2021-09-20       Impact factor: 60.716

Review 4.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

5.  Influence of vitamin D on cancer risk and treatment: Why the variability?

Authors:  M Rita I Young; Ying Xiong
Journal:  Trends Cancer Res       Date:  2018

6.  Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.

Authors:  Michael B Cook; Matthew J Barnett; Cathryn H Bock; Amanda J Cross; Phyllis J Goodman; Gary E Goodman; Christopher A Haiman; Kay-Tee Khaw; Marjorie L McCullough; Christine C Newton; Marie-Christine Boutron-Ruault; Eiliv Lund; Martin Rutegård; Mark D Thornquist; Michael Spriggs; Carol Giffen; Neal D Freedman; Troy Kemp; Candyce H Kroenke; Loïc Le Marchand; Jin Young Park; Michael Simon; Lynne R Wilkens; Ligia Pinto; Allan Hildesheim; Peter T Campbell
Journal:  Gut       Date:  2018-08-18       Impact factor: 23.059

Review 7.  The tumour immune microenvironment in oesophageal cancer.

Authors:  Maria Davern; Noel E Donlon; Margaret R Dunne; Robert Power; Conall Hayes; Ross King; John V Reynolds
Journal:  Br J Cancer       Date:  2021-04-26       Impact factor: 7.640

Review 8.  Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.

Authors:  Melissa Schmidt; Richard J Hackett; Ann-Marie Baker; Stuart A C McDonald; Michael Quante; Trevor A Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-02       Impact factor: 46.802

Review 9.  Redirecting the focus of cancer immunotherapy to premalignant conditions.

Authors:  M Rita I Young
Journal:  Cancer Lett       Date:  2017-01-24       Impact factor: 8.679

Review 10.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

Authors:  Michael B Cook; Aaron P Thrift
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.